Indian-Origin Leader Is New Singapore President
September 1, 2023
Full List of The 2024 NAACP Image Awards Winners
March 18, 2024
The Final Twist That Defied All Expectations
May 13, 2024
This came after the firm presented the Phase IV study protocol titled “A Phase IV, post-marketing, prospective, multicentre, single-arm clinical ...
New Delhi: Stating that the decision to waive off the clinical trial will be taken after a review of the ...
New Delhi: In response to the proposal presented by the drug major Hetero Labs to manufacture and market Elagolix tablet ...
New Delhi: With the condition to exclude patients with significant cardiovascular diseases from the trial, the Subject Expert Committee (SEC) ...
Present revised Phase III CT protocol : CDSCO Tells Hetero Lab on Antidiabetic FDC Drug We use cookies for analytics, ...
Hetero Group to invest Rs 1000 crore to expand pharma, specialist business in Andhra Pradesh We use cookies for analytics, ...
Submit justification: CDSCO Panel tells Hetero for FDC Lacosamide, Brivaracetam We use cookies for analytics, advertising and to improve our ...
HYDERABAD: Pharma player Hetero Group on Monday said it has emerged as the first in the world to receive the ...
Retail prices be calculated based on market data: NPPA Panel on Hetero Healthcare Lidocaine Patches We use cookies for analytics, ...
Trademark Infringement: Delhi HC rejects Sun Pharma plea against Hetero over cancer drug Letroz We use cookies for analytics, advertising ...
© 2022 Money Haat - Designed By JSD Solutions.